Delivery Order SPE2DB22D2206-SPE2DB25FJK37
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. The contract, valued at $7,255.25, carries a firm fixed price and is scheduled for completion by October 8, 2025. This competitively awarded delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of TREMFYA 200 mg/2 ml pen injections valued at $7,255.25. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 14, 2025, with performance taking place at the contractor's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child contract issued under AmerisourceBergen's substantial Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of TREMFYA 200 mg/2 mL pens valued at $21,765.75 under a firm fixed-price contract structure. This competitively awarded, non-set-aside delivery order is scheduled for completion by August 5, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen injections on September 12, 2025, with a ceiling value of $7,255.25 and a firm fixed price structure. This is a non-set-aside competitive award, with performance to be completed by October 3, 2025, at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction within a larger pharmaceutical supply relationship between the contractor...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of TREMFYA 200 mg/2 mL pen injections. The contract is firm fixed price with no set-aside designation and is scheduled for completion by October 20, 2025. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a competitively awarded transaction under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for TREMFYA 200 mg/2 mL pen injections valued at $7,255.25. This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under AmerisourceBergen's larger pharmaceutical supply contract vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, with an ultimate completion date of October 15, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,255.25 to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen injections on August 6, 2025, with an ultimate completion date of August 27, 2025. This firm fixed price, competitively awarded contract (no set-aside designation) is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award is a child order under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (SPE2DX)...
- The Defense Logistics Agency awarded a $8,341.55 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of TREMFYA 100 MG/ML pen injectors. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 9, 2025, and performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a $7,255.25 delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 ml pen injections on August 28, 2025, with completion targeted for September 19, 2025. This firm fixed-price contract represents a non-set-aside competitive award for pharmaceutical supply to support federal medical procurement needs. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for TREMFYA 200 mg/2 mL pen injections valued at $14,510.52 under a firm fixed price contract. The delivery order, issued on September 8, 2025, has an ultimate completion date of September 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside award issued through open competition, reflecting AmerisourceBergen's established...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJK37Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of TREMFYA 200 mg/2 ml pen injections valued at $7,255.25. This firm fixed-price, competitively awarded delivery order carries an ultimate completion date of September 4, 2025, and will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. The contract represents a non-set-aside procurement, indicating the award was made through open competition on the federal marketplace. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal military and veteran healthcare systems. The company maintains an extensive portfolio of federal contract awards with DLA and other government agencies, delivering a comprehensive range of pharmaceutical products and medical supplies across multiple therapeutic domains. This particular delivery order for TREMFYA, a specialty dermatological injection, exemplifies the company's role in supporting the Defense Health Agency and other federal healthcare systems with brand-name medications and specialized medical commodities that sustain military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 8/13/25 |